Sandoz Group AG (SDZNY)
Company Info
Highlights
$21.10B
0.13
$34.51 - $50.76
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Sandoz Group AG (SDZNY) returned 25.04% year-to-date (YTD) and 44.52% over the past 12 months.
SDZNY
25.04%
16.74%
11.07%
44.52%
N/A
N/A
N/A
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of SDZNY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 17.95% | -8.31% | -4.29% | 3.48% | 16.74% | 25.04% | |||||||
| 2024 | 7.33% | -9.56% | -3.12% | 12.56% | 6.31% | 2.00% | 19.96% | 1.37% | -5.49% | 9.63% | -0.04% | -11.17% | 28.41% |
| 2023 | -2.64% | 10.55% | 12.14% | 20.70% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 87, SDZNY is among the top 13% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Sandoz Group AG (SDZNY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Sandoz Group AG provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 |
|---|---|---|
| Dividend | $0.00 | $0.50 |
Dividend yield | 0.00% | 1.23% |
Monthly Dividends
The table displays the monthly dividend distributions for Sandoz Group AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.50 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.50 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Sandoz Group AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Sandoz Group AG was 25.34%, occurring on Apr 7, 2025. Recovery took 37 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -25.34% | Feb 14, 2025 | 36 | Apr 7, 2025 | 37 | May 30, 2025 | 73 |
| -20.68% | Oct 17, 2023 | 11 | Oct 31, 2023 | 43 | Jan 3, 2024 | 54 |
| -19.05% | Feb 1, 2024 | 48 | Apr 10, 2024 | 17 | May 3, 2024 | 65 |
| -13.29% | Nov 5, 2024 | 39 | Dec 31, 2024 | 14 | Jan 23, 2025 | 53 |
| -10.57% | Aug 28, 2024 | 25 | Oct 2, 2024 | 18 | Oct 28, 2024 | 43 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Sandoz Group AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Sandoz Group AG is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for SDZNY, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, SDZNY has a P/E ratio of 0.0. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for SDZNY compared to other companies in the Drug Manufacturers - Specialty & Generic industry. SDZNY currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SDZNY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, SDZNY has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SDZNY in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, SDZNY has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |